Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5063029 | 6233683 | I | 5063029-9 | 20000620 | 20060711 | 20060724 | EXP | 2006088341 | PFIZER INC | F | N | 20060721 | LW | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5063029 | 1007511682 | PS | PROVERA | 1 | ORAL | ORAL | D | D | 11839 | ||
| 5063029 | 1007540738 | SS | MEDROXYPROGESTERONE ACETATE | 1 | ORAL | ORAL | D | D | |||
| 5063029 | 1007540743 | SS | ESTRACE | 1 | D | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5063029 | 1007511682 | HORMONE REPLACEMENT THERAPY |
| 5063029 | 1007540738 | HORMONE REPLACEMENT THERAPY |
| 5063029 | 1007540743 | HORMONE REPLACEMENT THERAPY |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5063029 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5063029 | BREAST CANCER FEMALE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5063029 | CSM |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5063029 | 1007511682 | 19971001 | 20000601 | ||
| 5063029 | 1007540738 | 19971001 | 20000601 | ||
| 5063029 | 1007540743 | 19971001 | 20000601 |